Novuson
Bothell, US · Founded 2014 · 1 known investors
Novuson is developing patented DTU (Direct Therapeutic Ultrasound) surgical devices for vessel sealing and dividing, soft tissue ablation, and hemostasis without passing electric current through the patient. Its product line includes a 3mm Mini LS sealer/divider and a 10mm UltraStat MAXX device aimed at surgical and trauma applications.
BiotechHardwareHealthtechMedical Devices
Founders & leadership
FP
Francesco P CurraExecutive Officer, Director
CE
Christoph E MackExecutive Officer, Director
SB
Stuart B MitchellExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.4MraisedMar 2020 · 29 investors · BiotechnologyRule 506(b)
▶$2.4MraisedMar 2020 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stuart B MitchellExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.4M
- Minimum investment
- $50K
- First sale
- Sep 2017
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$500KraisedOct 2015 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedOct 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Francesco P CurraExecutive Officer, Director
- Christoph E MackExecutive Officer, Director
- Stuart B MitchellExecutive Officer, Director
- Offering amount
- $5.8M
- Amount sold
- $500K
- Minimum investment
- $25K
- Placement agents
- Novuson Surgical, Inc.
- First sale
- Oct 2015
- Incorporated
- Corporation, Washington, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.